Skip to main content
Top

Cancer and Metastasis Reviews

Issue 4/2010

Content (18 Articles)

NON-THEMATIC REVIEW

Regulatory T cells and breast cancer: implications for immunopathogenesis

Maria Angelica Ehara Watanabe, Julie Massayo Maeda Oda, Marla Karine Amarante, Julio Cesar Voltarelli

NON-THEMATIC REVIEW

Expression of tenascin-C and its isoforms in the breast

David S. Guttery, Jacqueline A. Shaw, Kirsty Lloyd, J. Howard Pringle, Rosemary A. Walker

NON-THEMATIC REVIEW

Obesity and breast cancer: status of leptin and adiponectin in pathological processes

Michael E. Grossmann, Amitabha Ray, Katai J. Nkhata, Dmitry A. Malakhov, Olga P. Rogozina, Soner Dogan, Margot P. Cleary

NON-THEMATIC REVIEW

DNA repair pathways and their implication in cancer treatment

Athanasios G. Pallis, Michalis V. Karamouzis

Open Access NON-THEMATIC REVIEW

Perspectives on the mesenchymal origin of metastatic cancer

Leanne C. Huysentruyt, Thomas N. Seyfried

NON-THEMATIC REVIEW

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

Xueqing Sun, Guangcun Cheng, Mingang Hao, Jianghua Zheng, Xiaoming Zhou, Jian Zhang, Russell S. Taichman, Kenneth J. Pienta, Jianhua Wang

Open Access NON-THEMATIC REVIEW

Cytochrome P450-derived eicosanoids: the neglected pathway in cancer

Dipak Panigrahy, Arja Kaipainen, Emily R. Greene, Sui Huang

NON-THEMATIC REVIEW

Distant metastases do not metastasize

Dieter Hölzel, Renate Eckel, Rebecca T. Emeny, Jutta Engel

NON-THEMATIC REVIEW

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

Carlos A. Castaneda, Hernán Cortes-Funes, Henry L. Gomez, Eva M. Ciruelos

NON-THEMATIC REVIEW

Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis

Phulwinder K. Grover, Jennifer E. Hardingham, Adrian G. Cummins

Open Access NON-THEMATIC REVIEW

Malignant melanoma as a target malignancy for the study of the anti-metastatic properties of the heparins

Anthony Maraveyas, Miriam J. Johnson, Yu Pei Xiao, Simon Noble

NON-THEMATIC REVIEW

Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis

Ming Shi, Dan Liu, Huijun Duan, Beifen Shen, Ning Guo

Erratum

Erratum to: microRNAs and lung cancer: tumors and 22-mers

Liqin Du, Alexander Pertsemlidis

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine